Molecular characterization of the ligand binding site of the human galanin receptor type 2, identifying subtype selective interactions
Open Access
- 15 September 2007
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 103 (5) , 1774-1784
Abstract
To define the specific role of the galanin receptors when mediating the effect of galanin, effective tools for distinct activation and inhibition of the different receptor subtypes are required. Several of the physiological effects modulated by galanin are implicated to be mediated via the GalR2 subtype and have been distinguished from GalR1 effects by utilizing the Gal(2–11) peptide, recognizing only GalR2 and GalR3. In this study, we have performed a mutagenesis approach on the GalR2 subtype and present, for the first time, a molecular characterization of the interactions responsible for ligand binding and receptor activation at this receptor subtype. Our results identify four residues, His252 and His253 located in transmembrane domain 6 and Phe264 and Tyr271 in the extracellular loop 3, to be of great significance. We show evidence for the N‐terminal tail of GalR2 to participate in ligand binding and that selective binding of Gal(2–11) includes interaction with the Ile256 residue, located at the very top of TM 6. In conclusion, we present a mutagenesis study on GalR2 and confer interactions responsible for ligand binding and receptor activation as well as selective recognition of the Gal(2–11) peptide at this receptor subtype. The presented observations could be of major importance for the design and development of new and improved peptide and non‐peptide ligands, selectively activating the GalR2 subtype.Keywords
This publication has 47 references indexed in Scilit:
- A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclinical testsNeuroscience Letters, 2006
- Galanin acts as a neuroprotective factor to the hippocampusProceedings of the National Academy of Sciences, 2004
- Galanin in Alzheimer DiseaseMolecular Interventions, 2003
- Molecular modelling and site-directed mutagenesis of human GALR1 galanin receptor defines determinants of receptor subtype specificityProtein Engineering, Design and Selection, 2002
- Galanin receptor subtypes and ligand bindingNeuropeptides, 2000
- Galanin receptor subtypesTrends in Pharmacological Sciences, 2000
- The N Terminus of Kaposi's Sarcoma-associated Herpesvirus G Protein-coupled Receptor Is Necessary for High Affinity Chemokine Binding but Not for Constitutive ActivityJournal of Biological Chemistry, 1999
- The Role of Amino Acids in Extracellular Loops of the Human P2Y1 Receptor in Surface Expression and Activation ProcessesJournal of Biological Chemistry, 1999
- Mutagenesis and Ligand Modification Studies on Galanin Binding to its GTP‐Binding‐Protein‐Coupled Receptor GalR1European Journal of Biochemistry, 1997
- Interaction of Substance P with the Second and Seventh Transmembrane Domains of the Neurokinin-1 ReceptorBiochemistry, 1994